ALPMY - Astellas Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
32.28B
Enterprise Value 3
32.82B
Trailing P/E
20.38
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.87
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 325.09%
S&P500 52-Week Change 325.78%
52 Week High 317.50
52 Week Low 312.77
50-Day Moving Average 317.14
200-Day Moving Average 315.45

Share Statistics

Avg Vol (3 month) 342.3k
Avg Vol (10 day) 328.3k
Shares Outstanding 51.87B
Float 1.89B
% Held by Insiders 10.00%
% Held by Institutions 10.24%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.37
Forward Annual Dividend Yield 42.12%
Trailing Annual Dividend Rate 30.34
Trailing Annual Dividend Yield 31.94%
5 Year Average Dividend Yield 42.08
Payout Ratio 430.27%
Dividend Date 3Dec 17, 2014
Ex-Dividend Date 4Sep 25, 2019
Last Split Factor 2125:100
Last Split Date 3Apr 01, 2014

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 18.85%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)10.30%
Return on Equity (ttm)19.15%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-0.50%
Gross Profit (ttm)1.01T
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.85
Quarterly Earnings Growth (yoy)42.00%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)0.23
Current Ratio (mrq)1.77
Book Value Per Share (mrq)6.06

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A